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USP45 and Spindly are part of the 
same complex implicated in cell 
migration
Claudia Conte1,3, Eric R. Griffis1,4, Ian Hickson2,5 & Ana B. Perez-Oliva  1
Ubiquitylation is a protein modification implicated in several cellular processes. This process is reversible 
by the action of deubiquinating enzymes (DUBs). USP45 is a ubiquitin specific protease about which 
little is known, aside from roles in DNA damage repair and differentiation of the vertebrate retina. 
Here, by using mass spectrometry we have identified Spindly as a new target of USP45. Our data show 
that Spindly and USP45 are part of the same complex and that their interaction specifically depends 
on the catalytic activity of USP45. In addition, we describe the type of ubiquitin chains associated with 
the complex that can be cleaved by USP45, with a preferential activity on K48 ubiquitin chain type 
and potentially K6. Here, we also show that Spindly is mono-ubiquitylated and this can be specifically 
removed by USP45 in its active form but not by the catalytic inactive form. Lastly, we identified a new 
role for USP45 in cell migration, similar to that which was recently described for Spindly.
Protein activity within the cell can be regulated through several post-translational modification processes to 
expand any given protein’s functional repertoire. Ubiquitylation is one of the major modifications that occurs in 
the cell; it consists of the addition of one or several subunits of the small and highly conserved molecule, called 
ubiquitin1. The addition of ubiquitin requires the action of three enzymes: the ubiquitin-activating enzyme (or 
E1), a step requiring ATP as energy source; the ubiquitin-conjugating enzyme (or E2), which allows the transfer 
of ubiquitin from E1 to E2 via a trans-(thio)- esterification reaction; and lastly the E3 ligase enzyme (or E3) that, 
by interacting with both the E2 and the substrate, generates an isopeptide bond between a lysine of the target 
protein and the C-terminal glycine of the ubiquitin molecule2,3. This process plays an important function in the 
regulation and in the degradation of many proteins depending on where and how many molecules of ubiquitin 
are attached to the target protein4. Ubiquitin molecules can be linked through one of the seven ubiquitin Lys res-
idues (which are K6, K11, K27, K29, K33, K48 and K63) or through the ubiquitin amino terminal Met1 residue 
(which generates linear chains)5. Different roles have been associated with different kinds of chains6.
The ubiquitination process is reversible thanks to the activity of deubiquitinating enzymes (DUBs). So far, 
these enzymes have been divided into 5 families: Ubiquitin C-Terminal Hydrolases (UCHs), Ubiquitin-Specific 
Proteases (USPs), Machado-Joseph Disease Protein Domain Proteases (MJDs), Ovarian Tumor Proteases (OTUs), 
Monocyte Chemotactic Protein Induced Protein Proteases (MCPIP) and JAB/MPN/Mov34 Metalloenzyme 
(JAMM) domain Proteases7,8. Only the JAMMs are metallo proteases, while the rest of the families are cysteine 
proteases. The activity of DUBs has been implicated in several important pathways including cell growth and dif-
ferentiation, development, oncogenesis, neuronal disease and transcriptional regulation. In addition, they have a 
crucial role in controlling proteasome dependent protein degradation, endocytosis and DNA damage repair9–11.
The largest family of DUBs is represented by USPs, papain-like isopeptidases with a common catalytic domain 
that varies greatly in size (50–300 kDa), and that usually contain an N-terminal domain with function in substrate 
recognition, subcellular localization and/or protein-protein interaction12. USPs can process ubiquitin precursors, 
remove ubiquitin from protein conjugates and disassemble ubiquitin chains. In general the members already 
characterized show a promiscuous activity against almost all ubiquitin chains. USP45 belongs to the USPs family 
of proteases and it has been shown to play a role in DNA damage regulating ERCC1 ubiquitin levels as well as its 
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recruitment to DNA damage sites. It has been also described that USP45 can be recruited to DNA damage sites 
dependent upon its catalytic activity but independently of its interaction with ERCC-XPF complex13. On the 
other hand, a recent publication described a role of USP45 in vertebrate retina differentiation; using a morpholino 
approach the authors show that knockdown of USP45 showed a moderate to severe morphological eye defect in a 
zebrafish model. This phenotype is associated with retina formation and differentiation and the authors postulate 
USP45 as a candidate for causing hereditary retinal dystrophies14.
Spindly, also called CCDC99, is a coiled-coil domain containing protein, already described as an important 
regulator of the mitotic checkpoint15–17.
Spindly was identified through two RNAi screens in Drosophila melanogaster S2 cells, where its specific deple-
tion generated alterations in cytoskeletal architecture and in mitotic progression17. After its discovery, several 
publications have been focused on describing the role of Spindly in mitosis15,16,18–23. Spindly plays an important 
role at kinetochores where it can interact with components of the RZZ complex (Rod/ZW10/Zwilch) as well as 
the dynein-dynactin complex20,24,25. In addition, a recent publication showed that Spindly associates with the 
cell cortex and colocalizes with dynein/dynactin at the leading edge of migrating cells. In this publication, the 
authors showed that cells lacking Spindly migrate slower than wild type cells and that this effect is rescued by 
re-expression of wild-type Spindly, whereas a mutant specifically defective in dynactin binding fails to rescue 
the phenotype26. These data are the first description of the importance of Spindly in the cell migration process in 
human cells.
In this study, we have used mass spectrometry to identify Spindly as a new interactor of USP45. Our data 
indicate that Spindly and USP45 are part of the same protein complex and that the interaction depends on the 
catalytic activity of USP45. In addition, we identified ubiquitin chains associated with the complex that can be 
cleaved by USP45, with a preferential activity on K48 ubiquitin chains. Moreover, we demonstrated that Spindly 
is not ubiquitylated in a K48-polyubiquitin manner, suggesting that there must be at least a third component of 
the complex. Interestingly, we could detect a monoubiquitylation of Spindly, which could be specifically removed 
by USP45. Additionally, in this study we show that USP45 plays a role analogous to Spindly in cell migration. Our 
data indicate that the lack of USP45 reduces migration velocity compared to wild-type cells.
Results
Spindly a new interactor of USP45. In order to ascertain the function of USP45, we performed immuno-
precipitation assays against endogenous USP45 as has been previously described in13, using the same set of anti-
bodies and cell lines (WT and Knockout (KO) of USP45). As described in13, the KO of USP45 was generated in 
KBM7 and U2OS cells by targeting exon 2 of USP45 using CRISPR/Cas9 technology as described in27. These cell 
lines were used to perform a mass spectrometry analysis to identify new potential targets of USP45. In addition 
to the DNA damage complex (ERCC1-XPF), where USP45 can interact with ERCC1 through its N-term domain, 
already described, and the proteins previously reported by Sowa et al., (such as RBMX, MYH10 and MYH9)28, 
we identified a new potential target of USP45 encoded by the SPDL1 gene called Spindly or CCDC99. Spindly is 
a protein recruited to kinetochores in mitosis that plays a critical role in cell division, and a role for this protein in 
cell migration has been reported recently26. The protein-protein interaction result was confirmed in both KBM7 
(suspension cell lines) and U2OS (adherent cell lines) cells, expressing USP45 WT but not in a USP45 KO cell 
lines (Fig. 1A,C and MS supp data). To validate the data of mass spectrometry, co-immunoprecipitation assays 
were performed using endogenous USP45 followed by immunoblot that validated the interaction between endog-
enous Spindly and endogenous USP45 (Fig. 1B,D).
To confirm the presence of both these proteins in the same complex we carried out a gel filtration study. 
Previous gel filtration studies of USP45 have established that in HEK293 cells extracts, USP45 is distributed in 
2 fractions, one pool eluted in high molecular weight fractions and the other pool eluted in lower molecular 
weight fractions13. Exploring the elution profile of USP45 and Spindly we found that both proteins co-eluted in 
the high molecular weight fractions (fractions 5–10) (Fig. 1E). Moreover, endogenous immunoprecipitation of 
USP45 from these aforementioned fractions (5–10) further confirmed the presence of both proteins in a com-
plex (Fig. 1F). Finally, a co-immunoprecipitation for Spindly from HEK293 cells overexpressing Spindly-FLAG, 
followed by immunoblotting for endogenous USP45, confirmed the interaction between both proteins (Fig. 1G).
Catalytic activity of USP45 is essential to the interaction with Spindly. In order to map the region 
of USP45 interacting with Spindly, we performed co-immunoprecipitation studies from HEK293 cells transiently 
expressing different USP45 fragments GFP tagged (Fig. 2A). From our data, the catalytic activity of USP45 seems 
to be essential; the full length USP45 protein with the catalytic cysteine mutated to alanine (C199A) was not able 
to interact with Spindly (Fig. 2A). In addition, a truncated version of USP45 lacking the catalytic domain (frag-
ment 1–170) failed to interact with Spindly (Fig. 2A).
To further validate the co-immunoprecipitation result, we conducted an “in vivo” study exploiting the 
FRB-FKBP system. This method is based on the hetero-dimerization capacity of these two proteins (FRB and 
FKBP) only upon addition of rapamycin as was described in Putyrski et al.29 and the method section herein. 
Therefore, first we generated a mCherry-Spindly-FKBP tagged construct and then we co-transfected U2OS cells 
with three different plasmids: mCherry-Spindly-FKBP, Lin11-FRB and GFP-USP45 (separate constructs). The 
Lin11-FRB protein allows for conditional plasma membrane recruitment of the FKBP-tagged proteins. In the 
absence of rapamycin, mCherry-Spindly was distributed in the cytosol and USP45 in both cytosol and nucleus. 
Upon addition of rapamycin, Spindly-FKBP was recruited to the plasma membrane and colocalization with 
GFP-USP45 WT was observed, confirming protein-protein interaction (Fig. 2B). Interestingly, neither the cat-
alytic inactive USP45 construct (C199A) nor the 1–170 fragment could be recruited to the plasma membrane. 
On the other hand, the 61-end fragment and the 189-end fragment of USP45 (both maintaining the catalytic 
activity intact) were positively recruited (Fig. 2B). Another DUB, USP51, was also tested as a negative control and 
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Figure 1. USP45 co-immunoprecipitates Spindly. (A) Endogenous USP45 was immunoprecipitated (IP) 
from wild-type (WT) or knock-out (KO) KBM7 cell lines. The immunoprecipitates were resolved on a 
polyacrylamide gel and stained with Coomassie. The gel was divided into the indicated sections (black lines) 
and proteins were identified by mass spectrometry analysis. (B) Endogenous USP45 was immunoprecipitated 
from WT or USP45 KO KBM7 cell lines and subjected to immunoblotting with indicated antibodies. (C) 
Endogenous USP45 was immunoprecipitated from WT and USP45 KO U2OS cell lines and analysed as in 
(A). (D) Endogenous USP45 was immunoprecipitated from WT or USP45 KO U2OS cell lines and subjected 
to immunoblotting with indicated antibodies. (E) Extracts of HEK293 cells were analysed by gel filtration 
on a Superdex 200 10/300 GL preparative grade column (GE Healthcare) in buffer containing 0.15 M NaCl, 
and every second fraction from 80 fractions obtained were denatured and analysed by immunoblotting with 
the indicated antibodies. (F) Fractions (5–10) of gel filtration analysis were used to immunoprecipitated 
endogenous USP45 and subjected to immunoblotting with the indicated antibodies. (G) Extracts of 
HEK293 overexpressing Spindly-FLAG were subjected to immunoprecipitation anti-FLAG and 10% of the 
immunoprecipitated proteins were analysed by immunoblotting for anti-FLAG and 90% for endogenous 
USP45. (A–G) All experiments were performed at least three times and a representative example is shown.
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Figure 2. The catalytic activity of USP45 is essential for its interaction with Spindly. (A) U2OS cells 
were transiently transfected with the indicated GFP fusion constructs encoding full-length or indicated 
fragments of USP45 (left-hand side panel). Thirty six hours post-transfection cells were lysed and GFP 
immunoprecipitated. The immunoprecipitates were resolved on a polyacrylamide gel and stained with 
Coomassie (right-hand side upper panel) or subjected to immunoblotting with the indicated antibodies 
(right-hand side lower panel). GFP empty vector was used as a negative control. (B) U2OS cells were 
transfected with the indicated USP45 constructs GFP tagged, mCherrySpindly-FKBP and Lin11-FRB for 
40 hours. Lin11 expression allows for mislocalisation recruitment at the plasma membrane of the FKBP-
tagged protein. Rapamycin (4 μM) was administered for 1 hour (at 37 °C) and then cells were visualized under 
a fluorescence microscope: USP45 construct (green), Spindly (red). Left-hand side panel DMSO treated 
samples; right-hand side Rapamycin treated samples. 60X magnification. Scale bars: 5 μm. GFP-USP51 was 
used as negative control. (C) Yeast two-hybrid (Y2H) assays were performed with a GAL4 DNA-binding 
domain fusion or activation domain for each protein indicated in the table to detect interaction between 
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the specificity of the USP45 interaction was confirmed (Fig. 2B). These results further underline the importance 
of DUB enzymatic activity in the interaction between USP45 and Spindly. Quantifications of all these assays in 
absence or presence of rapamycin are shown in Supp. Fig. 1.
In order to elucidate if the interaction is direct between both proteins or if they are part of the same complex 
but do not interact directly, we performed a yeast two hybrid assay. As described previously13 we used ERCC1 as 
a positive control for the experiment and as can be observed in Fig. 2C. Although Spindly and USP45 seems to be 
part of the same complex they do not interact directly.
K48 ubiquitin chains that can be cleaved by USP45 are part of the Spindly complex. Given 
that USP45 is a DUB, we decided to explore the ubiquitylation in the Spindly-USP45 complex. To do so, U2OS 
cells were transfected with Spindly-FLAG and after immunoprecipitation of the flag-tagged protein, total ubiq-
uitin was analysed (Fig. 3A, left panel). A considerable amount of ubiquitin chains were co-immunoprecipitated 
with Spindly, indicative of potential Spindly ubiquitylation and/or the presence of multiple other ubiquitylated 
proteins in the same complex. Moreover, when these immunoprecipitated ubiquitylated proteins were treated 
with recombinant USP45 WT or the catalytically inactive USP45 C199A mutant, the ubiquitins were removed 
only by the wild-type USP45 but not by the mutant. Our data therefore indicate that USP45 could deubiqui-
tylate Spindly and/or the other ubiquitylated proteins in the complex. Observing the Spindly immunoblot in 
more detail, we noticed only a small doublet of Spindly (native Spindly band plus a small higher band), but 
no higher molecular weight bands, so we concluded that Spindly is not polyubiquitylated under these condi-
tions (Fig. 3A, right panel). A further validation of this data was obtained by treating cells with the proteasome 
inhibitor Lactacystin to test if we were able to observe Spindly polyubiquitylation; we did not see any accumu-
lation of high molecular-weight species of Spindly in this condition (Supp. Fig. 2A). This suggests that Spindly 
could be potentially be mono-ubiquitylated instead of poly-ubiquitylated: Treatment of the IP of Spindly-FLAG 
with recombinant USP45 WT showed a removal of the potential Spindly mono-ubiquitylation band (Fig. 3A, 
right panel). To confirm that Spindly is a substrate of USP45 we carried out the classical ubiquitin Rhodamine 
(Ub-Rho110-G) assay as described in13 where USP45 activity can be measured. As is shown in Supp. Fig. 2B, 
activity of recombinant USP45 WT is impacted by addition to the reaction of the immunoprecipitated Spindly 
FLAG due to competition of both substrates for the enzyme activity. No activity was observed in recombinant 
USP45 C199A in the absence or presence of Spindly.
In order to explore ubiquitin specificity of USP45, in vitro de-ubiquitylation assays with 8 ubiquitin substrates 
were performed. Results are shown in Supp. Fig. 2C, wherein USP45 has preference for K6, K48 and K63 ubiq-
uitin chains, limited activity on K11 and K33 and no activity against other ubiquitin types. To further analyse 
this specificity, we performed a time course assay with the most common studied ubiquitin types (K48 and K63) 
plus K6, another ubiquitin type preferred by USP45. Results shown in Supp. Fig. 2D indicate that recombinant 
USP45 WT is able to mediate the cleavage of 100% of the K6, K48 and K63 dimer in 60 min. As a negative control 
recombinant USP45 C199A was used.
To further analyse the nature of the ubiquitin chains implicated in the complex, we repeated the same exper-
iment as in Fig. 3A, blotting in this case with a K48-specific anti-ubiquitin chain antibody or a K63-specific 
anti-ubiquitin chain antibody. The results indicate that ubiquitin chains of K63 ubiquitin can immunoprecipitate 
with Spindly but they are not affected by USP45 activity whereas K48 specific ubiquitin chains not only immu-
noprecipitate with Spindly but also can be processed by enzymatically active USP45 but not by the inactive form 
(Fig. 3B). We cannot exclude the presence of K6 ubiquitin chains implicated in the complex as well, due to the 
USP45 specificity demonstrated against them, but the lack of commercial antibodies against K6 impairs further 
exploration of this30. Since we already confirmed that Spindly was not poly-ubiquitylated in K48 chains (Supp. 
Fig. 2A), we performed several follow up experiments to search for potential Spindly interactors as well as kineto-
chore proteins (the site where Spindly has been described to have its main function), these proteins included 
Dynein (Dynein intermediate chain, DIC), Dynactin (p50), RZZ complex (ZW10 and KNTC1). In all cases, all 
proteins were analysed after Spindly IP in absence or presence of recombinant USP45 WT or catalytic inactive 
protein. However, to date, we have been unable to identify the protein of the complex that is polyubiquitylated in 
K48 ubiquitin type chains (Supp. Fig. 3A).
USP45 is a DUB that catalyses the de-monoubiquitylation of Spindly. Monoubiquitylation is a 
protein modification that occurs when a single ubiquitin is bound to a single lysine on the target protein. This 
process has been reported to be independent from degradation. To explore further if the monoubiquitylation of 
Spindly observed in Fig. 3A is real and if it is modulated by USP45, we performed an immunoprecipitation assay 
of FLAG-Spindly and we treated the beads with increasing amounts of recombinant USP45 WT, from 0 to 16 ng. 
We observed that 2 ng of recombinant USP45 WT was sufficient to remove the monoubiquitylation of Spindly. 
As a negative control, we used the catalytically inactive USP45 C199A mutant at maximum concentration (16 ng) 
and we did not observe any removal of Spindly monoubiquitylation (Fig. 4A). To cleave total ubiquitin associated 
with the Spindly complex, higher amounts of recombinant USP45 WT were necessary; again as a negative control 
USP45 C199A mutant was used.
To test the specificity of USP45 in the process we did a similar assay using a panel of DUBs from different 
families. After immunoprecipitation of Spindly, beads were treated with recombinant USP45 WT and C199A, and 
the indicated proteins. Cells grown in media lacking LEU, TRP and HIS with increasing concentrations of 
3-amino, 1,2,4 triazole (to select for bait and prey plasmids). (A–C) All experiments were performed at least 
three times and a representative example is shown.
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with DUBS with different specific preference of ubiquitin chain type cleavage, such as AMSH (K63), CEZANNE 
(K11), OTUB1 (K48) and OTULIN (Linear chains). Immunoblots for total ubiquitin showed that ubiquitin 
chains associated with Spindly can be cleaved only by active USP45 as well as the mono-ubiquitin observed on 
Spindly after immunoprecipitation (Fig. 4B).
In order to identify the lysine mono-ubiquitylated in Spindly we performed a mass spec analysis with a 
Gly-Gly antibody and 2 lysines were identified as a potential target sites in peptides analysed (MS supp data). We 
generated single and double mutants of these potential sites: residues 115 and 117 to arginine, but we failed in the 
specific identification of the site, probably because other lysines can be ubiquitylated in absence of these specific 
ones (Supp. Fig. 4). It is important to mention that Spindly protein contains 62 lysine residues in its sequence.
USP45 has a role in cell migration. To understand in what biological process these two proteins could be 
interacting, first we analysed the levels of phospho-H3, a marker for mitotic cells in WT and USP45 KO U2OS 
cell lines. Spindly has been described as an active player in cell division, acting at kinetochores in complex with 
other proteins15,19. Our results however indicate that the absence of USP45 does not affect mitotic progression 
and therefore the role of USP45 role is probably not related to Spindly in mitosis (Supp. Fig. 5). In addition, both 
Figure 3. K48 ubiquitin chains that are cleaved by USP45 are part of the Spindly complex. (A) U2OS cells were 
transiently transfected with a construct encoding FLAG-Spindly. Thirty-six hours post-transfection cells were 
lysed and immunoprecipitation against anti-FLAG performed. The precipitates were treated in the absence or 
presence of 0.1 μg of recombinant USP45 wild-type (WT) or catalytic inactive USP45 (C199A). Analysis was 
performed by immunoblotting for total ubiquitin (Total-Ubq FK2) (left-hand side) and immunoprecipitation 
was confirmed by immunoblot with anti-FLAG antibody (right-hand side). (B) Similar experiment as in A, 
developed with K63 ubiquitin specific chain (left panel) and K48 ubiquitin specific chain antibody (right panel). 
(A,B) All experiments were performed at least three times and a representative example is shown.
www.nature.com/scientificreports/
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USP45 WT and USP45 KO cells have a similar cell cycle profile as described in13. We also analysed the rate of 
cytokinesis in cells depleted of USP45. The process of cytokinesis can be followed by staining actin with phalloi-
din and following the formation of the actin ring over time. However, upon USP45 KO cytokinesis was also not 
Figure 4. USP45 is a DUB that catalyses the di-monoubiquitylation of Spindly. (A) HEK293 cells were 
transfected with Spindly-FLAG. Spindly-FLAG was immunoprecipitated and treated in the absence or presence of 
increasing concentration of recombinant USP45 wild-type (WT) or catalytic inactive USP45 (C199A) at highest 
concentration. The immunoprecipitates were resolved on a polyacrylamide gel and subjected to immunoblotting 
with the indicated antibodies (upper and lower panels) or stained with Coomassie (middle panel). (B) HEK293 
cells were transfected with Spindly-FLAG. Spindly-FLAG was immunoprecipitated and treated with several 
different DUBs. The immunoprecipitates were resolved on a polyacrylamide gel and subjected to immunoblotting 
with the indicated antibodies (upper and lower panel) or stained with Coomassie (middle panel). (A,B) All 
experiments were performed at least three times and a representative example is shown.
www.nature.com/scientificreports/
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Figure 5. Silencing of USP45 or Spindly leads to defects in cell migration. (A) U2OS cell lines either expressing 
USP45 WT or KO were analysed for cytokinesis rate. The figure shows that the lack of USP45 does not affect the 
cytokinesis process and cells division as show the DAPI staining. Staining as follow: Actin (Phalloidin, green), 
nuclei (DAPI, blue). 60X magnification. Scale bars: 5 μm. (B) Images from time-lapse analysis of wound healing 
assay of U2OS cells treated either with siRNA control (scramble) or siRNA for Spindly (siRNA Spindly). Dotted 
white lines indicate the edge of the wound. Three independent experiments were performed and data in the 
graph represent mean ± s.d. Scale bars: 10 μm. (A,B) All experiments were performed at least three times and a 
representative example is shown. (C) USP45 WT or KO U2OS cells. Transient transfection of USP45 KO U2OS 
cells with USP45 WT construct rescued the delay defects; while instead transient transfection of KO U2OS cells 
with catalytic inactive USP45 (C199A) construct maintain the defect. Dotted white lines indicate the edge of the 
wound. Three independent experiments were performed and data in the graph represent mean ± s.d. Student 
t-test was used to determine the statistical significance. Scale bars: 10 μm.
www.nature.com/scientificreports/
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altered, confirming that neither mitosis nor proliferation rate is affected by the lack of USP45 at 48 hours; results 
are shown in Fig. 5A.
Recent studies have shown that Spindly is required for proper cell migration, with its depletion causing defects 
in wound closure in a cell monolayer. Moreover, Spindly localises on microtubule tips and at focal adhesions 
suggesting a role in cell migration associated with the dynein-dynactin complex, with which it was already 
shown to interact26,31,32. Thus, we explored the potential role of USP45 in this process by performing the same 
wound-closure experiments as for Spindly depleted cells, using USP45 KO cells. We generated a wound in a mon-
olayer of cells to observe the edge driven movement promoted to close the gap (“wound”). The wound was gener-
ated by the use of a silicon chamber divided in the middle by a wall. Cells were seeded in the two wells and once 
confluence was reached the insert was removed, generating a reproducible gap in the monolayer of cells. Our data 
in USP45 KO cells showed similar results to what was obtained in cells lacking Spindly (Fig. 5B). USP45 depleted 
cells were defective in cell migration and the defects observed were not produced by off-target effects: phenotypic 
rescue could be achieved only by re-expressing the catalytically active USP45 and not with the inactive mutant 
C199A, suggesting a potential interplay of Spindly and USP45 in cell migration (Fig. 5C).
Discussion
Spindly is a key regulator of mitosis, due to its role in recruiting the dynein dynactin complex to kinetochores and 
its ability to activate the motility of the supercomplex. Recent work showed that C-terminal farnesylation of the 
protein is essential for these functions21–23. In this manuscript, we show that Spindly can be mono-ubiquitylated 
and associates with both a DUB protein, USP45, and a large complex of ubiquitylated proteins.
USP45 is a DUB with preference for K6, K48 and K63 ubiquitin chains, at least in vitro and limited activity is 
observed on K11 and K33 and no activity against other ubiquitin types. Moreover, here we described that USP45 
can both deubiquitylate Spindly and remove the K48 chains from proteins in the Spindly-binding complex and 
potentially K6 chains although currently available tools impairs the ability to explore this. Interestingly, the cata-
lytic activity of USP45 is required for the interaction between the DUB and the Spindly complex, which is highly 
unusual for DUB-target protein interactions as most DUBs recognize their substrates through non-catalytic 
regions. This could be explained if the interaction is through the ubiquitin motif as data from the yeast two hybrid 
assay reveals that the interaction between USP45 and Spindly is not direct or could be through a third, unknown 
ubiquitylated protein in the complex. This raises the question of whether USP45 needs to remove an ubiquitin or 
ubiquitin chain in order to recognize its binding partner. Given that the catalytically dead mutant cannot bind to 
the Spindly complex we favour this hypothesis for how USP45 interacts with the high-molecular weight ubiqui-
tylated complex. Our proposed model of the hypothesis is summarized in Fig. 6.
In spite of our efforts to identify the ubiquitylated site of Spindly and potential candidate lysines identified 
by mass spectrometry and mutation of residues 115 and 117 to arginine, so far we have been unable to find the 
specific site of modification. These residues, both are in the first Coil Coil Domain I of Spindly, which has been 
described as a region dispensable for its kinetochore localization23, these data correlate with our data that demon-
strate the lack of effect of USP45 in kinetochore formation or cell division, as discussed below. We hypothesise 
that in the absence of the normal target lysine in our mutant models, additional lysines within Spindly may 
undergo ubiquitylation and it is noted that the high number of lysine residues (62 within the Spindly sequence), 
provide some rationale for this proposal.
Curiously, USP45 activity does not appear to be required for the activity of Spindly at the kinetochore. USP45 
KO cells divide without any apparent delay. However, we cannot rule out that there is another DUB that can 
compensate for the lack of USP45 in these cells. We did find a phenotypic overlap between Spindly and USP45 in 
cell migration. The loss of either protein slows wound closure in a 2D cell migration model. Further research will 
be needed to definitively identify the mechanism by which USP45 affects migration and determine whether it is 
directly regulating Spindly in this behaviour.
Figure 6. Model of USP45 and Spindly interaction. Proposed model illustrating the interaction between USP45 
and Spindly. Interaction is dependent on USP45 catalytic activity. Spindly is mono-ubiquitylated and this 
ubiquitin can be removed by active USP45. K48 ubiquitylated complex that interacts with Spindly is also de-
ubiquitylated by USP45. In the absence of USP45 catalytic activity, interaction is abolished and cell migration is 
affected similarly to the phenotype described for lack of Spindly.
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Materials and Methods
Reagents. Ubiquitin monomer, BSA, Tris and DTT were purchased from Sigma Aldrich. Di-Ubiquitin 
topoisomers (linear, K6, K11, K27, K29, K33, K48 and K63-linked ubiquitin-ubiquitin) were purchased from 
Boston Biochem. Complete protease inhibitors cocktail tablets were obtained from Roche. Protein G–Sepharose, 
glutathione–Sepharose and ECL reagents were from GE Healthcare. Doxycycline, DMSO, BSA, 3-amino, 1,2,4 
triazole and benzamidine were from Sigma–Aldrich. PMSF was from Melford. Novex 4–12% polyacrylamide 
Bis-Tris gels, LDS sample buffer, puromycin, hygromycin, blasticidin and other tissue culture reagents were from 
Invitrogen Life Technologies. Instant Blue Coomassie stain was from Expedeon. PEI (polyethylenimine) was 
from Polysciences.
General methods. Standard protocols were used for tissue culture, electrophoresis, immunoblotting 
and immunoprecipitation as well as DNA procedures. The QuikChange® site-directed mutagenesis method 
(Stratagene) with KOD polymerase (Novagen) was used to generate mutants. DNA plasmids were purified 
using QIAGEN maxi-prep kits according to the manufacturer’s protocol from Escherichia coli DH5α cells. All 
DNA plasmids were sequenced by the Sequencing Service (MRC Protein Phosphorylation Unit, College of Life 
Sciences, University of Dundee, Dundee, U.K.; http://www.dnaseq.co.uk), using DYEnamic ET terminator chem-
istry (GE Healthcare) on Applied Biosystems automated DNA sequencers.
Antibodies. The following antibodies were raised by the Division of Signal Transduction Therapy (DSTT) at 
the University of Dundee in sheep and affinity-purified against the indicated antigens: anti-USP45 (1st, 2nd and 
3rd bleed of S052D, residues 756–780 of human USP45) and (1st, 2nd and 3rd bleed of S109D, residues 29–80 of 
human USP45). Antibody against FLAG M2 clone was from Sigma Aldrich. Total FK2 ubiquitin antibody and 
K48-linkage-specific ubiquitin antibodies (clone Apu2) was from Millipore and K63-linkage-specific ubiquitin 
antibodies (D7A11) were from Cell Signaling. Secondary antibodies coupled to horseradish peroxidase were 
from Thermo Scientific.
Cell culture, treatments and cell lysis. DMEM (Dulbecco’s modified Eagle’s medium) supplemented 
with 10% FBS, 2 mM glutamine and 1x antibacterial/antimycotic solution was used to culture U2OS (human 
osteosarcoma cells) and HEK-293 (human embryonic kidney cells). Transient transfections of HEK-293 or U2OS 
cells were carried out using PEI from Polysciences. Lysis buffer containing 50 mM Tris/HCl (pH 7.5), 1 mM 
EGTA, 1 mM EDTA, 1% Triton X-100, 50 mM NaF, 10 mM sodium 2-glycerophosphate, 5 mM sodium pyrophos-
phate, 1 mM sodium orthovanadate, 0.27 M sucrose, 1 mM benzamidine (added before lysis), 1 mM PMSF (added 
before lysis) and 0.1% 2-mercaptoethanol (added before lysis) was used to lyse cells. To observe ubiquitylation in 
immunoblotting, cells were lysed in lysis buffer containing 20 mM NEM (Sigma Aldrich). Lysates were clarified 
by centrifugation at 16000 g for 15 min at 4 °C and either used for further experiments or frozen in liquid nitro-
gen and stored at −80 °C. Protein determination was performed using Bradford method with BSA as a standard. 
Lactacystin (Sigma Aldrich) was used at 5 µM for 6 hours.
Expression of DUB enzymes. For insect cell protein expression, appropriate cDNAs were cloned into the 
pFastBac vector, baculoviruses were generated to encode various Dac-tagged DUB enzymes. Sf21 cells were typ-
ically infected with P1 virus stocks 120 and harvested 48 hours later. Cells were lysed in Dac lysis buffer (40 mM 
Tris pH 7.5, 0.2% Triton-X 100, 0.5 mM EGTA, 0.1 mM EDTA, 1 mM DTT) supplemented with 1 mM Pefabloc 
and Leupeptin at 20 μg/ml then centrifuged to remove insoluble material. For protein purification, supernatants 
were subjected to affinity chromatography using ampicillin-Sepharose resin. The DUB enzymes were either eluted 
from the ampicillin-Sepharose by incubating 4x for 15 min with 1 resin volume of 50 mM Tris pH 7.5, 5% v/v 
glycerol, 100 mM NaCl, 10 mM ampicillin, 1 mM DTT, 0.03% Brij-35 or recovered by digesting the DUB off the 
Dac-tag using TEV-protease in 50 mM Tris pH 7.5, 100 mM NaCl, 0.03% Brij 35.
In vitro DUB assay. DUB in vitro activity was performed using the indicated concentrations of each DUB 
in bis-tris acrylamide gels. Both enzymes and immunoprecipitations substrates were freshly mixed in reaction 
buffer (40 mM Tris-HCl, pH 7.6, 5 mM DTT, 0.005% BSA) for each run. The reaction mixture was incubated at 
30 °C for 60 minutes. The reaction was stopped by adding the SDS loading buffer if the sample was used to run a 
bis-acrylamide gel.
Immunoblotting. Lysates (20 μg) were heated in SDS sample buffer and subjected to SDS-PAGE following 
by an electrotransfer to nitrocellulose membranes. Membranes were blocked in 50 mM Tris-HCl pH 7.5, 0.15 mM 
NaCl and 0.1% Tween (TBST) containing 5% skimmed milk for 1 hour. The membranes were then probed with 
the primary antibody (1 μg/ml for the sheep antibodies or 1000-fold dilution for the commercial antibodies) 
for 16 hours at 4 °C in TBST containing 5% skimmed milk (sheep antibodies) or 5% BSA (commercial antibod-
ies). Detection of protein was performed using horseradish peroxidase-conjugated secondary antibodies and 
enhanced chemiluminescence reagent.
Immunoprecipitation. Lysates (1–2 mg) were incubated at 4 °C for 1 hour on a shaking platform with 5 μl of 
protein G-Sepharose coupled to USP45 or commercial FLAG-beads. The immunoprecipitates were washed twice 
with 1 ml of lysis buffer containing 0.5 M NaCl and twice with buffer A (50 mM Tris-HCl pH 7.5, 0.1 mM EGTA 
and 0.1% 2-mercaptoethanol).
Identification of USP45 interacting protein by mass spectrometry. 50 mg of cell lysates were 
pre-cleared by incubation with 100 μl of pre-immune IgG covalently coupled to protein G-Sepharose for 1 hour 
at 4 °C on a rolling shaker. The supernatants were then incubated with 50 μg of anti-USP45 specific antibody 
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covalently coupled to protein G-Sepharose for 1 hour at 4 °C on a rolling shaker. The immunoprecipitates were 
washed three times with 10 ml of lysis buffer containing 0.5 M NaCl and twice with 10 ml of buffer A. The beads 
were re-suspended in a total volume of 30 μl of LDS sample buffer (Invitrogen). The samples were then filtered 
with a 0.44 μm Spin-X filter (Corning), reduced with 10 mM dithiothreitol, boiled and subjected to electropho-
resis on a NuPAGE Bis-Tris 4–12% polyacrylamide gel. Colloidal Coomassie stained gel was divided as into 
piece, each of which were washed with 0.1 M NH4HCO3 and 50% acetonitrile/50 mM NH4HCO3, alkylated with 
50 mM iodoacetamide in 0.1 M NH4HCO3 (30 min at room temperature), washed as above, dried, and incubated 
with 25 mM triethylammonium bicarbonate with 5 μg/ml trypsin overnight at 30 °C on shaker. The resultants 
peptides were submitted to LC-MS on a Proxeon EASY-nLC nano liquid chromatography system coupled to a 
Thermo-LTQ-Orbitrap mass spectrometer. Data files were searched against the SwissProt mouse database using 
Mascot (http://www.matrixsciences.com) run on an in-house system, with 10 p.p.m. mass accuracy for precursor 
ions and a 0.8 Da tolerance for fragment ions.
Rapamacyin mislocalisation assay. Plasmids used for this assay were generated as follows: the FKBP 
coding sequence was inserted before the stop codon of the Spindly gene using the In-Fusion cloning method 
(Clontech). The mcherry-Spindly plasmid was linearised with the primers TAAGCGGCCGCTCGAGTC 
TAGAGG and CTGTTGAGGGCACTGGGTCTCTGG, and FKBP was amplified with the primers CAGTG 
CCCTCAACAGGGAGTGCAGGTGGAGACTATCTCC and TCGAGCGGCCGCTTATTCCAGTTTT 
AGAAGCTCCACATCG in which the underlined regions are homologous to the breakpoints in the linearised 
mcherry-Spindly plasmid. After the ligation reaction, colonies were screened by PCR and confirmed by sequenc-
ing. The Lin11-FRB plasmid was a kind gift of Dr. A. Saurin.
U2OS cells were transfected with the FRB and FKBP plasmids and simultaneously with the GFP- target 
protein. After 24 hours, rapamycin was added at 4 µM and incubated for between 30 minutes and 4 hours. Cells 
were then fixed with a 4% PFA solution, obtained by diluting Paraformaldehyde 32% Solution (EM Grade) in 
PHEM 1X (60 mM PIPES, pH 6.9; 25 mM HEPES; 10 mM EDTA; 2 mM MgCl 2x 6H2O), for 10 minutes at room 
temperature. Slides were washed in PHEM-wash (PHEM + 0.1% Triton X-100), permeabilized in PHEM-T 
(PHEM + 0.5% Triton X-100) for 5 minutes and fixed again in 4% PFA for 10 minutes. After three washes in 
PHEM-wash slides were blocked in Abdil (TBS-0.1% Tween, 0.1% Azide, 2% BSA) for 1 hour before incubat-
ing for one hour with DAPI (1:500) to stain DNA. Slides were finally mounted using DAKO Mounting Media 
(Agilent Technologies).
High-resolution images were collected with an imaging system (DeltaVision Elite; GE Lifesciences) using 
either a 60x or a 100x objective lens.
Images were analysed using FiJi Software. Measurements were conducted by drawing a line across the two 
edges of a cell and measuring the fluorescence intensity for both channels (green (GFP) and red (mCherry)). 
Graphs represent the average of data from three independent experiments for which at least 50 cells were meas-
ured each time.
Immunofluorescence. PFA 4% solution was obtained by diluting Paraformaldehyde 32% Solution 
(VWR) in PHEM 1X (60 mM PIPES, pH 6.9; 25 mM HEPES; 10 mM EDTA; 2 mM MgCl 2x 6H2O). Cells were 
seeded onto sterilised glass coverslips (Menzel-Glaser). When confluent, cells were fixed in 4% PFA for 10 min-
utes at room temperature, washed in PHEM-wash (PHEM + 0.1% Triton X-100), permeabilized in PHEM-T 
(PHEM + 0.5% Triton X-100) for 5 minutes and fixed again in 4% PFA for 10 minutes. After three washes in 
PHEM-wash they were blocked in AbDil buffer (TBS-0.1% Tween, 0.1% Azide, 2% BSA) for 1 hour. At this point 
slides were incubated with primary antibodies for one hour at room temperature or overnight at 4 °C.
After four washes in PHEM-wash, the coverslips were incubated for one hour with secondary (either Alexa 
or Jackson) antibodies diluted in AbDil buffer (1:500) and the DNA was stained with DAPI (Sigma) (1:500). 
Coverslips were washed three times in PHEM-wash and once in PHEM 1X prior to being mounted onto VWR 
SuperPremium Microscope Slides in DAKO mounting media (Agilent Technologies). Slides were finished with 
nail polish and allowed to dry before imaging was performed. High-resolution images were collected with an 
imaging system (DeltaVision Restoration; Applied Precision) using a 60X/1.35 oil (Olympus) objective lens. 
Images were then processed using FiJi software.
Cell migration assay and scratch assay. U2OS cells were seeded and cultured in a Silicone Culture-Insert 
(ibidi; Matinsried, Germany) set into a 35 mm µ-Dish (ibidi) and grown for at least 24 hours. Once cells reached 
confluence, the insert was removed and cells were washed once with fresh media, leaving the cells to migrate 
for the indicated times. For the rescue experiments, U2OS cells were transiently transfected with USP45 WT or 
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KO. Imaging was performed on a Nikon Ti microscope (Nikon, Tokyo, Japan) fitted with an OKOlab environ-
mental control chamber (Okolab, Pozzuoli, Italy), 20x 0.45NA objective, Nikon 421 PerfectFocus System, and a 
Photometrics Cascade II camera (Tucson, AZ, USA) and NIS Elements software. Images were then processed 
using FiJi software. Measurements were made by drawing a line between the edges and measuring the distance 
at the indicated time points. Kymograph analyses were conducted using Volocity software (Perkin Elmer; 425 
Waltham, MA, USA) to measure the velocity of movement over the time.
Yeast two-hybrid assay. Yeast strain used was AH109 (Invitrogen) which has a HIS3 gene regulated by 
Gal4-binding sites. This strain was transformed with a pAS2.6 plasmid (Invitrogen) encoding USP45 fused to the 
DNA-binding domain of Gal4 (the plasmid also has the TRP1 selectable marker) and with pACT2.6 plasmids 
(Invitrogen) encoding Spindly or ERCC1 fused to the Gal4 activation domain. As a negative control empty vec-
tors were used. Cells were plated in synthetic complete media lacking LEU and TRP and histidine (HIS), as well 
as in minimal medium lacking leucine (LEU) and tryptophan (TRP) to assay reporter gene activation. Colony 
growth was observed in each condition.
Rhodamine DUB assay. This assay was performed using rhodamine 110-glycine and 20 ng/μl of USP45 WT 
or catalytic inactive C199A at 30 °C for 1 hour in 40 mM Tris–HCl buffer at pH 7.6, with 5 mM DTT and 0.05 mg/
ml BSA. Samples were prepared in triplicates and analysed in 96-well plates using a Perkin Elmer Envision 2104 
multi-label reader at Excitation/Emission 485/535 nm.
In vitro DUB assays. DUB in vitro activity was performed using 50 ng of each DUB. Enzymes and substrates 
were freshly mixed in reaction buffer (40 mM Tris–HCl, pH 7.6, 5 mM DTT, 0.005% (w/v) BSA for each run. The 
reaction mixture was incubated at 30 °C for 60 min. The reaction was stopped by adding the SDS loading buffer 
when the sample was used to run a 15% (w/v) bis-acrylamide gel. For figure legends I would add:
Statistics. Student’s t-test was used to determine the statistical significance of rhodamine and H3 assay as well 
as migration speeds and wound closure dimensions.
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